Dr. Frank Breve is a clinical pharmacist consultant licensed in New Jersey, New York, Pennsylvania, Delaware, Maryland, West Virginia, Nebraska, and has been practicing as an independent consultant for more than 25 years. He is president and CEO of two consulting firms: Mid AtlanticPharmaTech Consultants, LLC and Opiate Consulting Educational Solutions. He is Adjunct Clinical Assistant Professor at Temple University School of Pharmacy, a former hospital clinical pharmacist at several large teaching facilities in the Philadelphia and southern New Jersey area, and past President of the New Jersey Pharmacists Association. Dr. Breve has expertise in clinical and regulatory consulting to healthcare systems with special emphasis on psychotropic agents and medications used to treat pain. Recent engagements include consulting for hospitals and narcotic treatment programs throughout the US and Canada for drug diversion issues.In addition to educational initiatives, Dr. Breve provides services to ensure regulatory compliance and continuous quality improvement for proper use, storage and monitoring of controlled substances, measures for prevention, and resolution for healthcare-related drug diversion. He is a member of the National Association of Drug Diversion Investigators, the Association of Healthcare Internal Auditors, and numerous pharmacy and medical professional organizations.